title: Multiple necrotic deep wound infections associated with a subcutaneous immunoglobulin infusion.
authors.affiliation: Department of Internal Medicine, McLaren Oakland Hospital, Pontiac, Michigan. Electronic address: latinaabraham@gmail.com.
authors.forename: Tina
authors.initials: T
authors.lastname: Abraham
authors.affiliation: University Hospitals, Regional Medical Centers, Richmond Heights, Ohio.
authors.forename: Yoon Mi
authors.initials: YM
authors.lastname: Kim
authors.affiliation: University Hospitals, Regional Medical Centers, Richmond Heights, Ohio.
authors.forename: Jason
authors.initials: J
authors.lastname: Casselman
authors.affiliation: Department of Internal Medicine, McLaren Oakland Hospital, Pontiac, Michigan; University Hospitals, Regional Medical Centers, Richmond Heights, Ohio.
authors.forename: Ali
authors.initials: A
authors.lastname: Saad
authors.affiliation: University Hospitals, Regional Medical Centers, Richmond Heights, Ohio.
authors.forename: Kathryn Ruda
authors.initials: KR
authors.lastname: Wessell
authors.affiliation: University Hospitals, Regional Medical Centers, Richmond Heights, Ohio.
authors.forename: Erin
authors.initials: E
authors.lastname: Toller-Artis
authors.affiliation: Allergy/Immunology Associates Inc, Mayfield Heights, Ohio.
authors.forename: Haig
authors.initials: H
authors.lastname: Tcheurekdjian
authors.affiliation: Allergy/Immunology Associates Inc, Mayfield Heights, Ohio.
authors.forename: Robert
authors.initials: R
authors.lastname: Hostoffer
mesh_terms: D018784:Abdominal Abscess / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002481:Cellulitis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D002981:Clindamycin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D017074:Common Variable Immunodeficiency / Q000628:therapy; D003646:Debridement; D057915:Drug Substitution; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D016756:Immunoglobulins, Intravenous; D055104:Infusions, Subcutaneous / Q000009:adverse effects; D000077731:Meropenem; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D008875:Middle Aged; D009336:Necrosis; D017511:Pyoderma Gangrenosum / Q000628:therapy; D012086:Reoperation; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D013845:Thienamycins / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use; D014946:Wound Infection / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000473:pathology
chemical_list: D000900:Anti-Bacterial Agents; D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D013845:Thienamycins; D002981:Clindamycin; D014640:Vancomycin; D000077731:Meropenem